- Home
- UBX vs BRN Comparison
UBX vs BRN Comparison
Compare UBX & BRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- BRN
- Stock Information
- Founded
- UBX 2009
- BRN 1956
- Country
- UBX United States
- BRN United States
- Employees
- UBX N/A
- BRN N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- BRN Oil & Gas Production
- Sector
- UBX Health Care
- BRN Energy
- Exchange
- UBX Nasdaq
- BRN Nasdaq
- Market Cap
- UBX 13.9M
- BRN 13.9M
- IPO Year
- UBX 2018
- BRN N/A
- Fundamental
- Price
- UBX $0.78
- BRN $1.21
- Analyst Decision
- UBX Strong Buy
- BRN
- Analyst Count
- UBX 3
- BRN 0
- Target Price
- UBX $4.67
- BRN N/A
- AVG Volume (30 Days)
- UBX 521.0K
- BRN 1.3M
- Earning Date
- UBX 08-05-2025
- BRN 08-12-2025
- Dividend Yield
- UBX N/A
- BRN N/A
- EPS Growth
- UBX N/A
- BRN N/A
- EPS
- UBX N/A
- BRN N/A
- Revenue
- UBX N/A
- BRN $19,387,000.00
- Revenue This Year
- UBX N/A
- BRN N/A
- Revenue Next Year
- UBX N/A
- BRN N/A
- P/E Ratio
- UBX N/A
- BRN N/A
- Revenue Growth
- UBX N/A
- BRN N/A
- 52 Week Low
- UBX $0.66
- BRN $1.15
- 52 Week High
- UBX $3.10
- BRN $2.53
- Technical
- Relative Strength Index (RSI)
- UBX 48.12
- BRN 43.48
- Support Level
- UBX $0.67
- BRN $1.16
- Resistance Level
- UBX $0.83
- BRN $1.58
- Average True Range (ATR)
- UBX 0.09
- BRN 0.26
- MACD
- UBX 0.01
- BRN -0.03
- Stochastic Oscillator
- UBX 24.67
- BRN 4.46
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.